N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine

C126H139N31O6 — CID 163691015

IUPACN,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine
SMILESCc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)c2c(n1)CN(CCc1ccn(C)n1)C2.Cc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)n2nc(OCc3ccn(C)n3)cc2n1.Cc1cccc(-c2cc(CN(C)C)n(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)CN(CCc3ccn(C)n3)C4)n2)c1
InChIInChI=1S/2C27H31N7O.C25H26N8O2.C25H29N5O.C22H22N4O/c1-20-4-3-5-21(16-20)24-8-11-34(30-24)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)10-7-22-6-9-31(2)29-22;1-20-16-24(21-6-4-3-5-7-21)30-34(20)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)11-9-22-8-10-31(2)29-22;1-18-14-21(19-6-4-3-5-7-19)28-32(18)23-16-25(31-10-12-34-13-11-31)33-22(26-23)15-24(29-33)35-17-20-8-9-30(2)27-20;1-18-6-4-7-19(14-18)23-15-20(17-28(2)3)30(27-23)25-16-24(29-10-12-31-13-11-29)21-8-5-9-22(21)26-25;1-16-4-2-5-17(14-16)19-8-9-26(24-19)22-15-21(25-10-12-27-13-11-25)18-6-3-7-20(18)23-22/h3-6,8-9,11,16-17H,7,10,12-15,18-19H2,1-2H3;3-8,10,16-17H,9,11-15,18-19H2,1-2H3;3-9,14-16H,10-13,17H2,1-2H3;4-7,9,14-16H,8,10-13,17H2,1-3H3;2-5,7-9,14-15H,6,10-13H2,1H3
InChIKeyJSYOHNHSKPXTCJ-UHFFFAOYSA-N
MW2183.71 g/mol
LogP17.14
Rot. Bonds26

About N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine

N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine (PubChem CID 163691015) has the molecular formula C126H139N31O6 and a molecular weight of 2183.71 g/mol. Its IUPAC name is N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine.

Molecular Properties

Compound NameN,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine
PubChem CID163691015
Molecular FormulaC126H139N31O6
Molecular Weight2183.71 g/mol
Exact Mass2182.15
IUPAC NameN,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine
SMILESCc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)c2c(n1)CN(CCc1ccn(C)n1)C2.Cc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)n2nc(OCc3ccn(C)n3)cc2n1.Cc1cccc(-c2cc(CN(C)C)n(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)CN(CCc3ccn(C)n3)C4)n2)c1
InChIInChI=1S/2C27H31N7O.C25H26N8O2.C25H29N5O.C22H22N4O/c1-20-4-3-5-21(16-20)24-8-11-34(30-24)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)10-7-22-6-9-31(2)29-22;1-20-16-24(21-6-4-3-5-7-21)30-34(20)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)11-9-22-8-10-31(2)29-22;1-18-14-21(19-6-4-3-5-7-19)28-32(18)23-16-25(31-10-12-34-13-11-31)33-22(26-23)15-24(29-33)35-17-20-8-9-30(2)27-20;1-18-6-4-7-19(14-18)23-15-20(17-28(2)3)30(27-23)25-16-24(29-10-12-31-13-11-29)21-8-5-9-22(21)26-25;1-16-4-2-5-17(14-16)19-8-9-26(24-19)22-15-21(25-10-12-27-13-11-25)18-6-3-7-20(18)23-22/h3-6,8-9,11,16-17H,7,10,12-15,18-19H2,1-2H3;3-8,10,16-17H,9,11-15,18-19H2,1-2H3;3-9,14-16H,10-13,17H2,1-2H3;4-7,9,14-16H,8,10-13,17H2,1-3H3;2-5,7-9,14-15H,6,10-13H2,1H3
InChIKeyJSYOHNHSKPXTCJ-UHFFFAOYSA-N
XLogP17.14
TPSA305.61 Ų
H-Bond Donors
H-Bond Acceptors37
Rotatable Bonds26
Heavy Atoms163
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002183.71
LogP ≤ 517.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1037

Analyze N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine?
The IUPAC name of N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine (CID 163691015) is N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine.
What is the SMILES notation for N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine?
The canonical SMILES for N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine is Cc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)c2c(n1)CN(CCc1ccn(C)n1)C2.Cc1cc(-c2ccccc2)nn1-c1cc(N2CCOCC2)n2nc(OCc3ccn(C)n3)cc2n1.Cc1cccc(-c2cc(CN(C)C)n(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)C=CC4)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)c4c(n3)CN(CCc3ccn(C)n3)C4)n2)c1.
What is the InChIKey of N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine?
The InChIKey is JSYOHNHSKPXTCJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C27H31N7O.C25H26N8O2.C25H29N5O.C22H22N4O/c1-20-4-3-5-21(16-20)24-8-11-34(30-24)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)10-7-22-6-9-31(2)29-22;1-20-16-24(21-6-4-3-5-7-21)30-34(20)27-17-26(33-12-14-35-15-13-33)23-18-32(19-25(23)28-27)11-9-22-8-10-31(2)29-22;1-18-14-21(19-6-4-3-5-7-19)28-32(18)23-16-25(31-10-12-34-13-11-31)33-22(26-23)15-24(29-33)35-17-20-8-9-30(2)27-20;1-18-6-4-7-19(14-18)23-15-20(17-28(2)3)30(27-23)25-16-24(29-10-12-31-13-11-29)21-8-5-9-22(21)26-25;1-16-4-2-5-17(14-16)19-8-9-26(24-19)22-15-21(25-10-12-27-13-11-25)18-6-3-7-20(18)23-22/h3-6,8-9,11,16-17H,7,10,12-15,18-19H2,1-2H3;3-8,10,16-17H,9,11-15,18-19H2,1-2H3;3-9,14-16H,10-13,17H2,1-2H3;4-7,9,14-16H,8,10-13,17H2,1-3H3;2-5,7-9,14-15H,6,10-13H2,1H3.
What are the key properties of N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine?
N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine has a molecular weight of 2183.71 g/mol, XLogP of 17.14, 26 rotatable bonds, 0 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-1-[3-(3-methylphenyl)-1-(4-morpholin-4-yl-5H-cyclopenta[b]pyridin-2-yl)pyrazol-5-yl]methanamine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-5H-cyclopenta[b]pyridin-4-yl]morpholine;4-[2-[3-(3-methylphenyl)pyrazol-1-yl]-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[2-(5-methyl-3-phenylpyrazol-1-yl)-6-[2-(1-methylpyrazol-3-yl)ethyl]-5,7-dihydropyrrolo[3,4-b]pyridin-4-yl]morpholine;4-[5-(5-methyl-3-phenylpyrazol-1-yl)-2-[(1-methylpyrazol-3-yl)methoxy]pyrazolo[1,5-a]pyrimidin-7-yl]morpholine is sourced from PubChem (CID 163691015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).